Bacteriophages and Their Components as Promising and Alternative Tools for the Control of Bacterial Pathogens
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 94364
Special Issue Editor
Interests: antibiotic resistance mechanisms; genetic bases for the diffusion of antibiotic resistance genes; microbial bioinformatics; new antimicrobial drugs; bacteriophages; bacteriophages as tools for phage therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The dissemination of bacterial pathogens, which often display complex antibiotic resistance phenotypes, constitutes a major global problem affecting human health at several diverse levels. These include, but are not limited to, hospital settings, agriculture and animal breeding. The appearance and wide dissemination of antibiotic-resistant bacteria observed over the last few decades could in fact lead to the establishment in all these settings of antibiotic-resistant “bad bugs”, which could possibly bring us back to a “pre-antibiotic era” in the near future. Therefore, fast and effective actions need to be taken to avoid this scenario. The slow pace of the classical antibiotic development pipeline and the rapid emergence of resistance to novel compounds frequently observed soon after their clinical use have led to renewed interest in Felix d’Herelle’s old idea of phage therapy. This option, already being successfully used mainly in Eastern European countries, has recently received attention at a world-wide scale, with several excellent examples that have proved its promising efficacy at clinical level.
The scope of this Special Issue is to collect original contributions on the use of bacteriophages or their selected components for fighting bacterial pathogens. It is expected that this Special Issue will collect research articles on new phage components with antimicrobial activity, to be used alone or in combination with conventional antibiotics, and reports on the use of bacteriophages for phage therapy. Detailed characterizations of newly discovered bacteriophages active against multidrug-resistant pathogens and with potential use as therapeutics are also welcomed. It is my pleasure to invite you to also submit review articles or short communications related to these topics.
Dr. Marco Maria D'Andrea
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bacteriophage
- phage therapy
- antibiotic resistance
- multidrug-resistant bacteria
- bacterial infection
- novel antimicrobial approach
- lysin
- depolymerase.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.